N.m.r. and molecular-modelling studies of the solution conformation of heparin
about
Crystal structure of a heparin- and integrin-binding segment of human fibronectin.Structural interactions of fibroblast growth factor receptor with its ligandsTransglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrixSolution structure of midkine, a new heparin-binding growth factorCrystal structure of the OpcA integral membrane adhesin from Neisseria meningitidisFibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblastsAntithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activationStructural basis for complement factor H linked age-related macular degenerationLaminin 332 processing impacts cellular behaviorCrystal structure of the TSP-1 type 1 repeatsThe heparin binding site of protein C inhibitor is protease-dependentCharacterization of the Structural Features and Interactions of Sclerostin: MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATIONProteoglycan-Specific Molecular Switch for RPTP Clustering and Neuronal ExtensionEndocytotic Routes of Cobra Cardiotoxins Depend on Spatial Distribution of Positively Charged and Hydrophobic Domains to Target Distinct Types of Sulfated Glycoconjugates on Cell SurfaceStructural basis for sialic acid-mediated self-recognition by complement factor HStructure of a heparin-linked biologically active dimer of fibroblast growth factorModel for the three-dimensional structure of vitronectin: predictions for the multi-domain protein from threading and dockingConformation of heparin pentasaccharide bound to antithrombin IIILow molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (I): preparation and characterizationPolySac3DB: an annotated data base of 3 dimensional structures of polysaccharidesConformations of the iduronate ring in short heparin fragments described by time-averaged distance restrained molecular dynamics.Structure of heparin-derived tetrasaccharide complexed to the plasma protein antithrombin derived from NOEs, J-couplings and chemical shifts.Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s).Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation.Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan InteractionsThe 2.8 Å Electron Microscopy Structure of Adeno-Associated Virus-DJ Bound by a Heparinoid Pentasaccharide.Heparinoids activate a protease, secreted by mucosa and tumors, via tethering supplemented by allostery.Extension and validation of the GLYCAM force field parameters for modeling glycosaminoglycans.How does heparin prevent the pH inactivation of cathepsin B? Allosteric mechanism elucidated by docking and molecular dynamicsMechanism of heparin acceleration of tissue inhibitor of metalloproteases-1 (TIMP-1) degradation by the human neutrophil elastaseStructural diversity of heparan sulfate binding domains in chemokinesCrystallographic analysis of calcium-dependent heparin binding to annexin A2.WISP-1 binds to decorin and biglycan.A triad of lys12, lys41, arg78 spatial domain, a novel identified heparin binding site on tat protein, facilitates tat-driven cell adhesion.Heparan sulfate: growth control with a restricted sequence menuEffect of the substituents of the neighboring ring in the conformational equilibrium of iduronate in heparin-like trisaccharides.The specificity of interactions between proteins and sulfated polysaccharides.Structural characterization of human heparanase reveals insights into substrate recognition.Structural specificity of heparin binding in the fibroblast growth factor family of proteins.
P2860
Q22009026-21BD3C42-D04D-4AA2-B681-DD4C03FECA8EQ22011005-6C4AEE9B-068E-4F23-A990-433391E45994Q24309155-3FB243FD-9FD1-4B6B-B883-825602CD89ABQ24310244-309D2635-ED56-46CA-A853-F58C2302610EQ24531430-9A70ABF8-CF26-4195-B545-D6A46C5D4590Q24534355-5AF732AB-65A7-44CE-B8CD-79B706736E0DQ24546028-36E526F3-95E3-4A09-9D8C-9DC5AD57D7B1Q24676448-4A28F0B7-D02B-4593-A9B7-CF5E17BBEAE3Q27021764-62F2DAF2-E196-4A47-B419-B3488F058B45Q27639866-98D84574-B68E-48F8-A66D-0EB9723E351FQ27652705-9F292802-43CF-42AB-82A0-2679B59C77A4Q27653715-58E285EB-DD08-4B6E-8EDA-81391BF8A71BQ27667397-E92C8666-1D3B-46C0-920B-A2C2350FD691Q27684078-953CD4C2-413D-4409-9A12-291E71129520Q27696183-618323A5-9740-4942-8672-CC5D516C7232Q27760195-AA49DB29-8A98-4A58-A20E-773714AE5C1DQ28206585-F0925BAB-E5DA-47CC-B7CF-A103A64D0CF5Q28360842-65AB62FB-B4B3-4C16-AF83-C5F1DB9AE0ADQ28366163-2018DACA-6BCF-4BEF-A29E-12C0AF9DCF33Q30577456-941A1744-D9DD-482B-B28D-DE11ACDF774FQ30658432-1C801F7C-8128-46AD-84F4-76F9DC5E94D7Q31271143-ACE545BF-E120-4D44-AE1F-73DA30430088Q33246009-155F2ED5-F583-49DF-9F10-C4C9C4CA7DCFQ33384039-1AA932EE-E0DC-4C0F-9086-41DE9170C991Q33583925-4BD1C064-854B-4F2F-B7EC-91D8DDBCB642Q33624473-FAF2385E-5155-4C96-9C09-994F65EC1437Q33633258-3F86AA8A-0A61-4E8B-9746-68A418F34164Q33777230-C0297D6F-2DB7-431A-9991-C0AB8A5D61EEQ33778115-F9FBE102-D32C-49EB-B902-C35032CDEEEEQ33787274-15A779A2-35AD-4DD7-8442-AC23FFC7AF91Q33952545-CACFBAE5-3940-4AFC-841A-B2C43F87E5CFQ34008721-91260CB8-483A-4495-985C-8000F0083C43Q34031628-FCA7A47C-83EA-4950-982F-9F8955F084D9Q34094910-D501DA05-41D8-4733-A78F-2BC1CD81E156Q34197864-00BC25A1-48C3-47C6-A758-D485FBF8D2C5Q34328757-202F5EC5-BA8A-4A3E-870A-D152D0A4E5E8Q34473542-6E809FF2-BF4B-4DDC-924F-B15382B3BE8DQ34474956-8CAC637F-69C3-44F6-B39E-480E64CE7BA7Q34501966-FA8B3039-2DA2-497C-8CCD-E39C293F2DE9Q34805392-44E099AF-078E-4B84-A747-5846DA63625A
P2860
N.m.r. and molecular-modelling studies of the solution conformation of heparin
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
N.m.r. and molecular-modelling studies of the solution conformation of heparin
@ast
N.m.r. and molecular-modelling studies of the solution conformation of heparin
@en
N.m.r. and molecular-modelling studies of the solution conformation of heparin
@en-gb
N.m.r. and molecular-modelling studies of the solution conformation of heparin
@nl
type
label
N.m.r. and molecular-modelling studies of the solution conformation of heparin
@ast
N.m.r. and molecular-modelling studies of the solution conformation of heparin
@en
N.m.r. and molecular-modelling studies of the solution conformation of heparin
@en-gb
N.m.r. and molecular-modelling studies of the solution conformation of heparin
@nl
prefLabel
N.m.r. and molecular-modelling studies of the solution conformation of heparin
@ast
N.m.r. and molecular-modelling studies of the solution conformation of heparin
@en
N.m.r. and molecular-modelling studies of the solution conformation of heparin
@en-gb
N.m.r. and molecular-modelling studies of the solution conformation of heparin
@nl
P2093
P2860
P356
P1433
P1476
N.m.r. and molecular-modelling studies of the solution conformation of heparin
@en
P2093
P2860
P304
P356
10.1042/BJ2930849
P407
P478
293 ( Pt 3)
P50
P577
1993-08-01T00:00:00Z